Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.95 USD | +1.96% | +1.14% | +72.05% |
May. 24 | Surface Transforms and FRP placings oversubscribed | AN |
May. 16 | Pennant Group Acquires Hospice Provider Nurses on Wheels | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The firm trades with high earnings multiples: 29.36 times its 2024 earnings per share.
- The company is highly valued given the cash flows generated by its activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+72.05% | 706M | D+ | ||
+0.57% | 3.14B | B- | ||
0.00% | 1.94B | - | ||
+20.42% | 1.8B | C | ||
-12.17% | 443M | - | ||
-43.47% | 310M | - | ||
-14.93% | 185M | - | ||
-17.25% | 131M | - | ||
+3.85% | 69.16M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PNTG Stock
- Ratings The Pennant Group, Inc.